Medications development at the National Institute on Drug Abuse: focus on cocaine.
NIDA Res Monogr
; 135: 57-70, 1993.
Article
en En
| MEDLINE
| ID: mdl-8289904
NIDA's MDD is faced with the formidable task of identifying, characterizing, and developing new chemical entities to combat substance abuse. The primary challenge is to find one or more medications that will be useful in treating cocaine addiction, withdrawal, and abstinence. In addition, a treatment for cocaine overdose is in progress. Methodological approaches include testing compounds that alter endogenous neurotransmitters and compounds that suppress conditioned cues and stimuli. Compounds that appear efficacious in these tasks and that have a satisfactory safety profile will be studied in humans.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Cocaína
/
Trastornos Relacionados con Sustancias
Límite:
Humans
Idioma:
En
Revista:
NIDA Res Monogr
Asunto de la revista:
TRANSTORNOS RELACIONADOS COM SUBSTANCIAS
Año:
1993
Tipo del documento:
Article
Pais de publicación:
Estados Unidos